Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Fulvestrant 85 Letrozole 79 Paclitaxel 76 pembrolizumab 72 Specimen Handling 67 Trastuzumab 62 Carboplatin 57 Magnetic Resonance Spectroscopy 52 ribociclib 49 Capecitabine 49 Anastrozole 48 pertuzumab 46 palbociclib 45 abemaciclib 41 exemestane 40 Tamoxifen 40 Cyclophosphamide 40 Biopsy 39 trastuzumab deruxtecan 31 Docetaxel 30 Radiotherapy 29 Taxes 28 Gemcitabine 25 Blood Specimen Collection 25 130-nm albumin-bound paclitaxel 25 Surveys and Questionnaires 23 olaparib 22 Standard of Care 22 sacituzumab govitecan 20 eribulin 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

EC regimen × Breast × 90 days × Clear all

NCT03609047 2026-05-12

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡